Michael is a Senior Director in the Breakthrough Change group, an innovation and transformation center at Pfizer HQ. His mission is to advance the company’s ambition to provide “Breakthroughs that change patients’ lives. His focus is on delivering first-in-class science and winning the digital race, which includes expanding the role of Artificial Intelligence in both business and drug discovery to increase productivity and identify new therapies to help patients.
Prior to Pfizer, Michael was a Consultant at Strategy& (a PWC company) and PA Consulting. He was also VP of technology at Phosplatin Therapeutics, a NYC biotech startup, and Director of BD and Commercial Operations at CombinatoRx.
Michael lives in Brooklyn, and in his spare time enjoys helping entrepreneurs get their ideas to market; with several successful launches, from KickStarter to biotech IPOs. His own inventions include a kitchen gadget for SkyMall, a dual language eReader App, and several medical diagnostics and products.
He has an MBA from Columbia Business School, and MS in Biomedical Engineering from Boston University, and a BA in Biology from University of Michigan.